We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. The efficacy of add-ons: selected IVF “add-on” procedures and future directions

    Since the advent of ART, technology has continuously evolved to improve embryology and pregnancy outcomes. However, not all technologies that are...

    Haley N. Glatthorn, Alan Decherney in Journal of Assisted Reproduction and Genetics
    Article 23 January 2022
  2. Brivaracetam use in clinical practice: a Delphi consensus on its role as first add-on therapy in focal epilepsy and beyond

    Background

    Antiseizure medications remain the cornerstone of treatment for epilepsy, although a proportion of individuals with the condition will...

    Simona Lattanzi, Valentina Chiesa, ... Stella Vergine in Neurological Sciences
    Article Open access 01 April 2024
  3. Comparison of add-on medications for persistent storage symptoms after α-blocker treatment in BPH patients – a network meta-analysis

    Background

    Patients with benign prostatic hyperplasia (BPH) receive α-blockers as first-line therapy to treat lower urinary tract symptoms; however,...

    Yi-Ting Su, Hsiao-Ling Chen, ... Hsiang-Ying Lee in BMC Urology
    Article Open access 03 October 2023
  4. Add-on-LUCAS2™-Reanimation am NEF Innsbruck

    Study goal

    The study goals were to analyze the course and compare it with patients who were only resuscitated manually as well as to record the...

    D. Schwaiger, A. Zanvettor, ... M. Baubin in Die Anaesthesiologie
    Article Open access 07 April 2022
  5. Dutasteride add-on treatment to tadalafil for patients with benign prostatic enlargement is similarly effective as dutasteride add-on treatment to alpha blocker: a propensity-score matching analysis

    Purpose

    To investigate the efficacy of dutasteride add-on treatment to tadalafil in patients with lower urinary tract symptoms (LUTS) suggestive of...

    Naoki Wada, Noriyuki Abe, ... Hidehiro Kakizaki in International Urology and Nephrology
    Article 01 April 2022
  6. Orales Add-on optimiert die Lipidsenkung

    Redaktion Facharztmagazine in MMW - Fortschritte der Medizin
    Article 19 April 2024
  7. Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study

    Introduction

    In randomized controlled trials, add-on brivaracetam (BRV) reduced seizure frequency in patients with drug-resistant focal epilepsy. Most...

    Simona Lattanzi, Laura Canafoglia, ... Lelia Zummo in Neurology and Therapy
    Article Open access 16 September 2022
  8. PNH: Faktor-D-Inhibitor zur Add-on-Therapie zugelassen

    Redaktion Facharztmagazine in Im Fokus Onkologie
    Article 27 June 2024
  9. Long-term outcomes with rituximab as add-on therapy in severe childhood-onset lupus nephritis

    Background

    Long-term data pertaining to rituximab as add-on therapy in childhood-onset lupus nephritis (cLN) is scarce.

    Methods

    A retrospective cohort...

    Eugene Yu-hin Chan, Sze-wa Wong, ... Desmond Yat-hin Yap in Pediatric Nephrology
    Article 26 June 2023
  10. Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma

    Purpose

    Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. Despite the best available treatment, prognosis remains poor....

    Erik Ehinger, Jan Kopecky, ... Peter Siesjö in BMC Neurology
    Article Open access 18 February 2023
  11. Therapeutic effect of Duhuo Jisheng Decoction add-on Tui-na manipulation on osteoarthritis of knee: a randomized controlled trial

    Background

    Knee osteoarthritis (KOA) is a common degenerative joint condition that causes disability and pain in the elderly population. The...

    Kin Ho Chan, Jessica Y. L. Ching, ... Zhi-**u Lin in Chinese Medicine
    Article Open access 10 July 2023
  12. Add-on radioiodine during long-term BRAF/MEK inhibition in patients with RAI-refractory thyroid cancers: a reasonable option?

    Dual modulation of the MAPK pathway with BRAF (e.g., dabrafenib) and MEK (e.g., trametinib) inhibitors has the potential to re-establish radioiodine...

    Filipe Miguel Montes de Jesus, Vittoria Espeli, ... Luca Giovanella in Endocrine
    Article Open access 16 May 2023
  13. Was bringt Nintedanib als Add-on?

    Beate Fessler in Pneumo News
    Article 28 February 2024
  14. Tolerability of clobazam as add-on therapy in patients aged 50 years and older with drug-resistant epilepsy

    Objective

    To evaluate the tolerability of clobazam in patients with drug-resistant epilepsy aged 50 years and older.

    Methods

    We performed a single...

    Elanagan Nagarajan, Timothy M. Lynch, ... Marjorie E. Bunch in Neurological Sciences
    Article 25 March 2023
  15. The Fractional exhaled Nitric Oxide (FeNO)- test as add-on test in the diagnostic work-up of asthma: a study protocol

    Background

    Asthma is a common disease characterized by chronic inflammation of the lower airways, bronchial hyperactivity, and (reversible) airway...

    T. (Tuba) Kaya, G.J. (Gert-Jan) Braunstahl, ... J.P.M. (Hanna) van der Valk in BMC Pulmonary Medicine
    Article Open access 15 April 2024
  16. An acromegaly case treated with clomiphene citrate: add-on treatment in primary medical therapy

    Introduction

    Acromegaly is a disease with various comorbidities and hypogonadism is a common comorbidity in patients with acromegaly. Herein, we aim...

    Esma Pehlivan Koroglu, Utku Erdem Soyaltin, ... Banu Sarer Yurekli in Hormones
    Article 08 November 2022
Did you find what you were looking for? Share feedback.